New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
October 5, 2017 – Mylan launched an AP-rated generic version of Bayer’s Avelox (moxifloxacin) 400 mg injection.
Download PDF
Return to publications
